Walleye Capital’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Walleye Capital's EDIT Position: Q3 2026 in Review
Walleye Capital reduced its Editas Medicine (EDIT) stake by 100% in Q3 2026, selling an estimated $537K and leaving 502 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #5858.
Walleye Capital first reported a position in EDIT in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.38M in Q3 2022. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Walleye Capital held 502 shares of Editas Medicine worth $1.29K as of Q3 2026.
- Walleye Capital sold 183,357 Editas Medicine shares in Q3 2026, an estimated $537K.
- Editas Medicine made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5858 holding.
- Walleye Capital first reported a position in Editas Medicine in Q1 2019 and has held it in 14 quarters since.
- Walleye Capital's Editas Medicine position peaked at $1.38M in Q3 2022.
- 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.